In­side Track: Be­hind the Scenes of a Ma­jor Biotech SPAC

6 days ago

How Mul­ti-Stake­hold­er Strate­gies for Ex­ter­nal Con­trol Arms Can Over­come Ap­proval and Ac­cess Bar­ri­ers

4 weeks ago

Mov­ing Out of the Clin­ic with Dig­i­tal Tools: Mo­bile Spirom­e­try Dur­ing COVID-19 & Be­yond

Last month

How Pa­tients with Epilep­sy Ben­e­fit from Re­al-World Da­ta

Last month

The DCT-OS: A Tech­nol­o­gy-first Op­er­at­ing Sys­tem - En­abling Clin­i­cal Tri­als

Last month

We need faster end­points for tar­get­ed can­cer drugs – here’s one we can use

Last month

Qual­i­ty Con­trol in Cell and Gene Ther­a­py – What’s Re­al­ly at Stake?

2 months ago

BY­OD Best Prac­tices: How Mo­bile De­vice Strat­e­gy Leads to More Pa­tient-Cen­tric Clin­i­cal Tri­als

2 months ago

Can we cre­ate a world free of pain?

2 months ago

Start­ing your clin­i­cal jour­ney with the end in mind – the val­ue of a drug de­vel­op­ment plan

2 months ago

From Clin­i­cal Strat­e­gy to De­vel­op­ment: Nav­i­gat­ing COVID-19 to Sup­port the Next Gen­er­a­tion of Pa­tient-Fo­cused Treat­ments

3 months ago

Top Five Rules for Suc­cess in De­cen­tral­ized Tri­als

3 months ago

Ac­cel­er­at­ing drug de­vel­op­ment with­out sac­ri­fic­ing safe­ty: How phar­ma­covig­i­lance is keep­ing pace with COVID-19 clin­i­cal re­search

3 months ago

Tar­get­ing a Po­ten­tial Vul­ner­a­bil­i­ty of Cer­tain Can­cers with DNA Dam­age Re­sponse

3 months ago

Forg­ing an In­no­v­a­tive Path in CNS Treat­ment

4 months ago

Is Aus­tralia the next Glob­al Des­ti­na­tion for Phase 2?

4 months ago

Vi­da Ven­tures: Pow­er­ing Break­throughs in Bio­phar­ma

4 months ago

Da­ta Lit­er­a­cy: The Foun­da­tion for Mod­ern Tri­al Ex­e­cu­tion

4 months ago

5AM Ven­tures: Fu­el­ing the Next Gen­er­a­tion of In­no­va­tors

5 months ago

I-Mab —A Biotech on the Rise with In­spired Sci­ence

5 months ago

Fos­ter­ing Re­silien­cy at the Cross­roads of Try­ing Times: A Tool­box for Em­ploy­ee Agili­ty

6 months ago

Hair­pins and Scis­sors - De­liv­er­ing a Non-Gene Edit­ed Al­lo­gene­ic CAR T Cell Ther­a­py for the Mass­es

6 months ago

Putting Da­ta to Work in a Pan­dem­ic

6 months ago

Clin­i­cal tri­al mon­i­tor­ing is about to change for­ev­er

6 months ago
1234 Next page Last page